TGF-β1 concentrations prior to PVI are influenced by AF and associated comorbidities causing oxidative stress and the activation of inflammatory processes with fibrosis formation, which was more pronounced in patients with persistent AF [21]. The gene discussed is TGFB1; the disease is atrial fibrillation.